Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-α2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers

Journal of Interferon and Cytokine Research

Volumn 18, Issue 2, 1998, Pages 75-80

  Blatt, Lawrence M ^a   Tong, Myron J ^b   McHutchison, John G ^c   Russell, James ^a   Schmid, Peter ^a   Conrad, Andrew ^a  

^a National Genetics Institute   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS TITRATION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031892672     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.75     Document Type: Article

References (20)

1. SHERLOCK, S. (1992). Viral hepatitis. Lancet 339, 802.
2. DAVIS, G.L., BALART, L.A., SCHIFF, E.R., LINDSAY, K., BODENHEIMER, H.C., JR., PERRILLO, R.P., CAREY, W., JACOBSON, I.M., PAYNE, J., DIENSTAG, J.L., VAN THIEL, D.H., TAMBURRO, C., LEFKOWITCH, J., ALBRECHT, J., MESCHIEVITZ, C., ORTEGO, T.J., GIBAS, A., and the HEPATITIS INTERVENTIONAL THERAPY GROUP. (1989). Treatment of chronic hepatitis C with recombinant Interferon alfa: a multicenter randomized, controlled trial. N. Engl. J. Med. 321, 1501-1506.
3. LIANG, T.J., JEFFERS, L.J., REDDY, K.R., DE MEDINA, M., PARKER, I.T., CHEINQUER, H., IDROVO, V., RABASSA, A., and SCHIFF, E.R. (1993). Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18, 1326-1333.
4. FATTOVICH, G., GIUSTINA, G., DEGOS, F., TREMOLADA, F., DIODATI, G., ALMASIO, P., NEVENS, F., SOLINAS, A., MURA, D., BROUWER, J.T., THOMAS, H., NJAPOUM, C., CASARIN, C., BONETTI, P., FUSCHI, P., BASHO, J., TOCCO, A., BHALLA, A., GALASSINI, R., NOVENTA, F., SCHALM, S.W., and REALDI, G. (1997). Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112, 463-472.
5. TONG, M.J., LEE, S.-Y., HWANG, S.-J., CO, R.L., LAI, P.P.C., CHIEN, D., and KUO, G. (1994). Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma. West. J. Med. 160, 133-138.
6. DIENSTAG, J.L. (1983). Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85, 439-462.
7. ALTER, M.J., MARGOLIS, H.S., KRAWCZYNSKI, K., JUDSON, F.N., MARES, A., ALEXANDER, W.J., HU, P.Y., MILLER, J.K., GERBER, M.A., SAMPLINER, R.E., MEEKS, E.L., and BEACH, M.J. (1992). The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327, 1899-1905.
8. HOOFNAGLE, J.H., and DI BISCEGLIE, A.M. (1997). The treatment of chronic viral hepatitis. N. Engl. J. Med. 336, 347-356.
9. CHEMELLO, L., CAVALLETTO, L., CASARIN, C. BONETTI, P., BERNARDINELLO, E., PONTISSO, P., DONADA, C., BELUSSI, F., MARTINELLI, S., ALBERTI, A., and the TRIVENETO VIRAL HEPATITIS GROUP. (1996). Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C. Ann. Intern. Med. 124, 1058-1060.
10. TONG, M.J., BLATT, L.M., McHUTCHISON, J.G., HURR, Y., CO, R., and CONRAD, A. (1997). Early prediction of response to interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology 26, 1640-1645.
11. LAU, J.Y.N., DAVIS, G.L., KNIFFEN, J., QIAN, K.P., URDEA, M.S., CHAN, C.S., MIZOKAMI, M., NEUWALD, P.D., and WILBER, J.C. (1993). Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341, 1501-1504.
12. POCKROS, P.J., TONG, M.J., LEE, W.M., VAN LEEUWEN, D.J., KEEFFE, E., BALA, K., KILLENBERG, P.G., FOUST, R.T., ROSENBLATE, H.J., PAYNE, K.M., FROMM, H., LESESNE, H.R., BLACK, M., SNYDER, R., GERRARD, T., CONRAD, A., BLATT, L.M., and the CONSENSUS INTERFERON STUDY GROUP. (1996). Relationship between biochemical and virological response to type I interferon therapy of chronic HCV infection. Hepatology 24, 155A.
13. GRETCH, D., LEE, W., and COREY, L. (1992). Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J. Clin. Microbiol. 30, 2145-2149.
14. YAMADA, G., TAKATANI, M., KISHI, F., TAKAHASHI, M., DOI, T., TSUJI, T., SHIN, S., TANNO, M., URDEA, M.S., and KOLBERG, J.A. (1995). Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22, 1351-1354.
15. YOSHIOKA, K., KAKUMU, S., WAKITA, T., ISHIKAWA, T., ITOH, Y., TAKAYANAGI, M., HIGASHI, Y., SHIBATA, M., and MORISHIMA, T. (1992). Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 16, 293-299.
16. STUYVER, L., ROSSAU, R., WYSEUR, A., DUHAMEL, M., VANDERBORGHT, B., VAN HEUVERSWYN, H., and MAERTENS, G. (1993). Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74, 1093-1102.
17. SIMMONDS, P., ALBERTI, A., ALTER, H.J., BONINO, F., BRADLEY, D.W., BRECHOT, C., BROUWER, J.T., CHAN, S.-W., CHAYAMA, K., CHEN, D.-S., CHOO, Q.-L., COLOMBO, M., CUYPERS, H.T.M., DATE, T., DUSHEIKO, G.M., ESTEBAN, J.I., FAY, O., HADZIYANNIS, S.J., HAN, J., HATZAKIS, A., HOLMES, E.C., HOTTA, H., HOUGHTON, M., IRVINE, B., KOHARA, M., KOLBERG, J.A., KUO, G., LAU, J.Y.N., LELIE, P.N., MAERTENS, G., McOMISH, F., MIYAMURA, T., MIZOKAMI, M., NOMOTO, A., PRINCE, A.M., REESINK, H.W., RICE, C., ROGGENDORF, M., SCHALM, S.W., SHIKATA, T., SHIMOTOHNO, K., STUYVER, L., TRÉPO, C., WEINER, A., YAP, P.L., and URDEA, M.S. (1994). A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19, 1321-1324.
18. TONG, M.J., HWANG, S.-J., LEFKOWITZ, M., LEE, S.-D., CO, R.L., CONRAD, A., SCHMID, P., and LO, K.-J. (1994). Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J. Gastroenterol. Hepatol. 9, 587-591.
19. HOOFNAGEL (1997) Hepatitis C: the clinical spectrum of disease. Hepatology 26(Suppl. 1), 11S-14S.
20. HUANG, Y., BLATT, L.M., and TAYLOR, M.W. (1995). Type T interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1β and induction of interleukin-1 receptor antagonist. J. Interferon Cytokine Res. 15, 317-321.